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Abstract
Type II (proteic) chromosomal toxin-antitoxin systems (TAS) are widespread in Bacteria and Archaea but their precise
function is known only for a limited number of them. Out of the many TAS described, the relBE family is one of the most
abundant, being present in the three first sequenced strains of Streptococcus pneumoniae (D39, TIGR4 and R6). To address
the function of the pneumococcal relBE2Spn TAS in the bacterial physiology, we have compared the response of the R6-
relBE2Spn wild type strain with that of an isogenic derivative, DrelB2Spn under different stress conditions such as carbon and
amino acid starvation and antibiotic exposure. Differences on viability between the wild type and mutant strains were found
only when treatment directly impaired protein synthesis. As a criterion for the permanence of this locus in a variety of
clinical strains, we checked whether the relBE2Spn locus was conserved in around 100 pneumococcal strains, including
clinical isolates and strains with known genomes. All strains, although having various types of polymorphisms at the vicinity
of the TA region, contained a functional relBE2Spn locus and the type of its structure correlated with the multilocus
sequence type. Functionality of this TAS was maintained even in cases where severe rearrangements around the relBE2Spn
region were found. We conclude that even though the relBE2Spn TAS is not essential for pneumococcus, it may provide
additional advantages to the bacteria for colonization and/or infection.
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Introduction
Chromosomally-encoded Type II toxin-antitoxin systems (TAS),
composed of two proteins, are widely spread among Bacteria and
Archaea. Typically, they are organized as operons in which the first
gene encodes the antitoxin (A) and the second the toxin (T). Both
proteins interact to generate a harmless TA complex that auto-
regulate their own synthesis. The A protein by itself is metabolically
unstable and is constitutively degraded by ATP-dependent proteases,
releasing a free and stable T protein that would kill or stop the growth
of the cells by disruption of key cellular processes [1]. A puzzling
observation derived from bio-informatics approaches is that many
bacteria and archaea harbour multiple copies of various TAS (e.g.
around 60 TAS in Mycobacterium tuberculosis [2]), being even more
abundant than previously envisaged [3,4]. Notwithstanding the
knowledge on the mechanisms of action of TAS [5] and the three-
dimensional structure of various TA protein complexes [6–12], little
is known on the role of these systems in the bacterial cell lifestyle. In
the case of plasmid-encoded TAS, they seem to be involved in the
stable maintenance (‘‘addiction’’) of the replicons by increasing their
chances of vertical transmission [13]. For the chromosomally-
encoded TAS, several interpretations have been given to their
ubiquity and abundance, though none has been demonstrated thus
far [14]. First, it has been proposed that TAS could act as stress
response elements that modulate growth by reducing macromolec-
ular synthesis. Hence, induction of these systems results in cell stasis
rather than in cell death, leading to viable but not cultivable cells
[5,15]. Inhibition of bacterial growth induced by the toxin was
reversed by expression of the cognate antitoxin or by the transfer-
messenger mRNA (tmRNA). Thus, toxins would induce a reversible
stasis that improves bacterial cell survival under extreme conditions
[15–17]. Second, some chromosomal TAS such as mazEF has been
considered as mediators of bacterial programmed cell death [18,19].
Unfavourable cell growth conditions could trigger this pathway and,
as a consequence, a subpopulation of bacterial cells would die. Death
of these cells would i) preserve the food for the remaining population,
ii) serve as a defence mechanism to restrict phage spreading, and iii)
act as a mechanism to eliminate cells with deleterious mutations. It
would seem that mazEF-mediated cell death is a population-
dependent phenomenon requiring a quorum sensing molecule,
termed extracellular death factor, which is a linear pentapeptide
(NNWNN) important for mazEF-mediating killing activity [20]. E. coli
strains defective in mazEF showed lower sensitivity to antibiotics than
the wild type, indicating that antibiotic addition could induce mazEF-
mediated cell death [21]. And third, comparison of the fitness of two
isogenic E. coli strains, one wild type (wt) and the other having
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subjected to short-term stressconditions (amino acid starvation, acidic
stress, antibiotic treatment, and long-term stationary phase) showed
no significant differences among them [22], pointing that TAS could
be involved only in long-term evolution [1]. However, some findings
have complicated further the interpretation of the TAS role: i) TAS-
defective cells showed a reduced ability for biofilm formation [23,24];
ii) TA-cassettes have been localized in both integrative and
conjugative genome elements that could have incorporated into the
bacterial chromosome and, within this context, they could promote
plasmid maintenance [2,25–28]; iii) TAS can work as anti-addiction
modules [29]; iv) they may play an essential role in development of
programmed cell death which leads to Myxococcus multicellular
development [30], and v) they may be linked to bacterial persistence
upon antibiotic exposure [31].
Genes for at least eight putative TAS are present in the
chromosome of the Gram-positive bacterium Streptococcus pneumoniae
(the pneumococcus): relBE1Spn, relBE2Spn, yefMyoeBSpn, higAB, phd/
doc, pezAT, tasAB,a n dhicAB [3,17,32]. Among these, only three of
them, namely relBE2Spn [33], yefM-yoeBSpn [34], and pezAT [7] have
been shown to be genuine TAS, whereas relBE1Spn was shown to be
non-functional [33]. Exposure of E. coli cells to RelE2Spn toxin
resulted in the arrest of cell growth, which was rescued by induction
of RelB2Spn antitoxin but only within a time-frame window: long-
time exposure to the toxin led to cultures unable to resume growth
[33]. We report here on the role of the pneumococcal relBE2Spn TAS
in the bacteria lifestyle. We have compared the behaviour of two
pneumococcal isogenic strains, wild type (wt) R6 and a relBE2Spn
mutant derivative (R6DrelB2Spn) [33] under different growth
conditions, and differences were found when cells were subjected to
stress conditions that impaired protein synthesis. The RelE2Spn toxin
could act as a modulator of protein synthesis under stress, but it could
also induce cell death when the level of protein synthesis was
dramatically reduced. Further, if relBE2Spn played a role in bacterial
fitness, then it should contribute to colonization and survival after
infection (an important part of the switch from commensal to
infective for a bacterium like S. pneumoniae). If this was the case, the
relBE2Spn genes should be ubiquitous in the S. pneumoniae population.
Thus, the presence and integrity of the relBE2Spn locus was tested in
100 strains from different sources. Unlike E. coli, where several strains
lacked the relBE operon [1,14], all pneumococcal strains analyzed
retained this locus in their chromosome. Although the relBE2Spn
operon exhibited various degrees of polymorphisms in the different
isolates, none of the changes impaired the functionality of the
relBE2Spn locus. A molecular model of the pneumococcal RelE2Spn
protein was constructed based on the three dimensional structure of
the RelBE complexes from Pyrococcus horikoshii (PhRelE) [10] and
compared with that of Methanococcus jannaschii (MjRelE) [11]. The
modelled RelE2Spn kept several residues related to the catalytic
activity of ribonucleases, which are also present in MjRelE. However,
these residues are missing in EcoRelE and PhRelE proteins
[10,35,36], raising the possibility that the two former RelE proteins,
albeit being ribonucleases, could use a mechanism of action different
than the one proposed for EcoRelE [12].
Results
Mutation of the relBE2Spn operon has no effect on
pneumococcal cell viability under either regular
conditions of growth or carbon starvation
We first tested the differences in growth (optical density at
650 nm, OD650) and viability (measured by determination of the
colony-forming units, cfu) between the two strains, R6 wt and its
relBE2Spn mutant derivative, R6DrelB2Spn (Table 1). The
mutant strain contains two mutated copies of the relB2 gene,
and has the relE2 gene placed away from its promoter, also
disrupting the translational coupling that appears to exist in this
pneumococcal operon [33]. RT-PCR assays showed that in the
mutant strain there was not detectable synthesis of relE2m R N A
(not shown). To perform the experiments, cultures of both
strains were grown 24 h, and OD650 and cfu were determined at
time intervals. No differences were found between the strains
during the entire period in which the cultures passed through
exponential (0–2 hrs), stationary (2–8 hrs), and autolysis (8–
24 hrs) phases of growth (Figure S1 A, B). Autolysis is a
distinctive property of S. pneumoniae whose cells show a tendency
to spontaneously lyse when the culture reaches the stationary
phase [37]. Autolysis plays an important role in the bacterial
infection by the release of virulence factors which may modulate
the inflammatory response [38]. Glucose starvation activates
relBE transcription in E. coli, probably because of degradation of
RelB by the protease Lon, an event that would lead to an
increase in free RelE toxin and a reduction in the number of cfu
[39]. In the case of S. pneumoniae, the sugars routinely used as a
carbon source are di-saccharides (sucrose or maltose) rather
than glucose because of poorer utilization of the latter [40].
Carbon-starved cultures of either wt or DrelB2Spn mutant cells
showed no differences although cessation of growth was
o b s e r v e df o re i t h e rs t r a i na s compared to sucrose-grown
cultures, and no decrease in viability was observed in either
sucrose-depleted culture (Figure S1 C, D).
The relBE2Spn operon modulates pneumococcal growth
under amino acid starvation
Serine hydroxamate (SHT) induces amino acid starvation
because it blocks incorporation of Ser residues into proteins by
interfering with the load of seryl-tRNA [41,42]. In E. coli,
addition of SHT (similarly to carbon starvation) resulted in an
increase of relBE transcription leading to the increase of free
RelE due to RelB Lon-dependent proteolysis [39]. Thus, we
Table 1. Bacterial strains and plasmids.
Bacteria Genotype
Reference/
source
E. coli TOP10 F-mcrA, D(mrr-hsdRMS-mcrBC),
W80lacZDM15DlacX74, recA1, deoR, araD
139D(ara-leu)7697, galU, galK, rpsL(St
R),
endA1, nupG
Invitrogen
S. pneumoniae R6Wild type [40]
S. pneumoniae
R6DrelB2Spn
R6, DrelB2Spn, Cm
R [33]
Plasmid Features
Reference/
source
pFUS2 pMB1, PBAD, araC, neo [50]
pNM220 mini-R1, pA1/O4/O3, bla, lacI
q [51]
pE2wt pFUS2, relE2Spnwt This work
pE71 pFUS2, relE2Spn7153 This work
pE81 pFUS2, relE2Spn8651 This work
pE600 pFUS2, relE2SpnK-600 This work
pEter pFUS2, relE2Spn7153ter This work
pB2wt pNM220, relB2Spnwt This work
doi:10.1371/journal.pone.0011289.t001
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S. pneumoniae under a SHT-mediated amino acid starvation. The
results (Figure 1A) showed that the growth of both cultures
almost stopped, quickly and in a similar manner, indicating that
cells entered into stasis. In contrast to sucrose starvation,
differences in viability between both strains were observed
(Figure 1B). In the mutant strain, a 50%-reduction in cfu was
detected during the first 90 min of SHT treatment, followed by
a slight recovery at longer times. Such a recovery was not
detected for the wt strain, in which a continuous reduction in
cfu was seen; these differencesw e r em o r ee v i d e n tw h e nt h ec f u
were plotted on a linear, rather than logarithmic scale
(Figure 1C). After the 180 min starvation period, SHT was
removed, cells were resuspended in fresh pre-warmed medium,
and incubation was continued for additional 180 min
(Figures 2A and 2B). SHT withdrawal allowed resumption of
bacterial growth. However, the mutant cells recovered and
entered into stationary phase faster than the wt, whereas the
latter showed a more prolonged exponential phase (Figure 2B,
inset). These results suggested to us that i) the mutant strain
could recover faster because it lacked toxin RelE, and ii) the wt
cells could have saved more efficiently their physiological
resources during stasis, allowing a full recovery after amino
acid starvation.
Blocking protein synthesis by erythromycin or
streptomycin treatment leads to antibiotic tolerance in
the relBE2Spn mutant
In addition to carbon- and amino acid-induced starvation,
treatment with inhibitors of protein synthesis also caused a relBE
transcriptional induction in E. coli [39]. We employed erythromy-
cin (Erm) which inhibits protein synthesis by binding to the 23S
rRNA, interfering with the amino acyl translocation [43]. Erm is
an effective agent against streptococcal infections and its minimal
inhibitory concentration (MIC) is low, since for selection for
pneumococcal Erm-resistant transformants, the concentration
1 mg.ml
21 is sufficient [44] and MIC for the majority of wild-
type isolates fall in the range of 0.032–0,125 mg.ml
21 (http://
www.eucast.org/mic_distributions/). To test whether the muta-
tion of relBESpn had any effect on cell-response to blocking protein
synthesis, pneumococcal cultures (wt and DrelB2Spn strains) were
challenged with two dosages of Erm, 0.1 and 1 mg.ml
21 (that is 10
and 100 fold MIC for R6, respectively), followed by OD650 and
cfu determination at different times. After the 20 min treatment,
growth of both cultures was stopped, concomitantly with a
progressive reduction in cfu (Figures 3A and 3B). At the end of the
incubation period (180 min), a 10 to 1000-fold reduction in cfu
was observed. Interestingly, the reduction in cfu was much more
pronounced (10- to 100-fold difference) in the wt than in the
Figure 1. Changes in the growth profile of S. pneumoniae cells of the R6 or the R6DrelB2Spn mutant strains after inhibition of protein
synthesis by SHT. S. pneumoniae cultures, wt (#) and mutant (D) cells, were grown exponentially until an OD650 =0.2. Then, SHT (1.5 mg.ml
21)
was added, and incubation proceeded. Growth was monitored by determination of the OD650 of the cultures treated (filled symbols) or untreated
(open symbols) with SHT (A). At the times indicated, the numbers of cfu were determined by plating appropriate cell dilutions on SHT-free medium,
and incubation for 36 h at 37uC (B). Percentages of viable cells from wt (x) or mutant (*) strains upon SHT-treatment (C) were calculated considering
the number of cfu at time zero of the treatment as 100%.
doi:10.1371/journal.pone.0011289.g001
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antibiotic treatment would induce a complete shut-off in protein
synthesis leading to cell stasis or even cell death. Then, lack of the
relBE2Spn operon would lead to antibiotic tolerance.
To confirm these observations, a test of bacterial viability was
performed by employment of the LIVE/DEAD Baclight (Invitro-
gen) stain method. The pneumococcal cultures were stained and
examined under the microscope: living cells were stained in green,
whereas dead cells were stained in red. Micrographs of the
pneumococcal cultures were taken at 0 and after 180 min of Erm
treatment. The results showed no significant differences between
both strains when the cultures were challenged with 0.1 mg.ml
21
of Erm (Figure 3C upper panel). When Erm concentration was
raised to 1 mg.ml
21, a drastic loss of viability in the wt strain was
found, which was not observed in the mutant cells (Figure 3C,
lower panel). We performed a similar experiment using strepto-
mycin (Sm), another protein synthesis inhibitor, at 20 mg.ml
21
(selection for transformants to Sm-resistance is 100 mg.ml
21). In
this case, we observed, again, that the mutant cells were more
tolerant to Sm-treatment than the wild type strain (Figure S2). We
conclude that the relBE2Spn operon seems to be activated when
protein synthesis is inhibited, so that under these unfavourable
Figure 2. Recovery of cell growth after removal of SHT. SHT-amino acid starved pneumococcal cells (180 minutes of starvation) were washed
twice and suspended into pre-warmed fresh medium, and incubation proceeded for the indicated times. Recovery of starvation was followed by
turbidity of the cultures (OD650)o fw t( #) and mutant (D) strains (A). The number of cfu was determined by plating appropriate dilutions of the cells
at the times indicated (B). Inset: Linear plot showing cell viability evolution after SHT removal in wt (#) or mutant (D) cultures.
doi:10.1371/journal.pone.0011289.g002
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response through stasis.
The relBE2Spn locus is conserved among S. pneumoniae
clinical isolates
We reasoned that if the expression of relBE2Spn could confer a
selective advantage to the pneumococcus, then a conservation of
this locus in the bacterial chromosome of most, if not all, isolates
should be expected, in spite of hyper-recombination typical for this
species [45]. A preliminary analysis was performed in a small set of
five Spanish clinical isolates, for which the presence of the
relBE2Spn and the yefM-yoeBSpn loci (another pneumococcal
TAS that was used as a control), was tested by PCR using
the oligonucleotide pairs relB2p/relE2c and yefMN/yoeBC,
respectively. The first pair was previously used to amplify the
relBE2Spn locus of R6 strain [33], the relE2c primer annealing
partially into the region encoding RelE2Spn toxin (Figure 4A). In
these five strains, amplification of the yefM-yoeBSpn locus was
feasible, in contrast to relBE2Spn (Figure 4B, left panel). However,
when oligonucleotide relE2tga (fully complementary to the 39
region encoding the toxin gene) was used instead of primer relE2C,
a PCR product was detected (Figure 4B, right panel). The size of
Figure 3. Inhibition of protein synthesis by Erm treatment. Cultures of R6 (#)o rR 6 DrelB2Spn mutant (D) cells were treated with two
concentrations of Erm, 1 mg.ml
21 (black symbols) or 0.1 mg.ml
21 (grey symbols). Growth was followed by absorbance at OD650 (A) of untreated (open
symbols) and treated (filled symbols) cultures. At the indicated times, appropriate dilutions of cells were plated and incubated as above (B) All
experiments were performed at least three times. LIVE/DEAD-staining of wt and the R6DrelBE2Spn cells (C). The cultures were harvested 180 min after
addition of Erm and stained with Baclight Bacterial viability Kit (Invitrogen). Live cells show green fluorescence, whereas dead cells fluoresce red.
Percentages of viable cells in every assay, calculated from the results of Figure 3B are indicated in parentheses.
doi:10.1371/journal.pone.0011289.g003
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2000 bp instead 650 bp), due to the presence of the IS1167
sequence (see below). The results obtained for the Spanish isolates
demonstrated that the five strains analyzed contained the
relBE2Spn locus and all but one (strain CipR-25) exhibited changes
compared to strain R6 in the chromosomal regions flanking the
relBE2Spn operon, whereas the region around the yefM-yoeBSpn
locus was kept intact.
These initial polymorphisms prompted us to perform a similar
search in a variety of clinical isolates. To this end, we chose more
strains from well-characterized collections of clinical isolates from
Spain and Poland [46–48]. The Spanish collection (Table S1)
consisted of 12 more isolates whose serotypes and majority of
sequence types (STs) had been characterized, with the exception of
four isolates for which STs were established in this study (Table S1).
Apart from its role in epidemiology, multi-locus sequence typing
(MLST) provides genetic information of the population structure
[45]. MLST is performed by comparison of the DNA sequences of
internal fragments of seven housekeeping genes of an isolate with
theseavailableattheMLSTdatabase(http://spneumoniae.mlst.net/
). Spanish strains were isolated from blood and sputum in the years
2002 and 2006. The Polish clinical isolates proceeded from the
National Medicines Institute pneumococcal collection, and amount-
ed to 58 isolates representing 37 serotypes and 52 different STs [48].
Figure 4. Presence of the reBE2Spn operon in the chromosome of isolates of S. pneumoniae. Genetic organization of the relBE2Spn and
yefM-yoeBSpn loci in the R6 strain; the position of promoters Prel and Pmb, respectively, are shown (A). The primers used in the PCR amplifications are
drawn as arrows, and the expected sizes of the corresponding PCR fragments are shown below. The PCR products detected using the oligonucleotide
pairs relB2p /relE2c and yefMN /yoeBC (left panel) or the oligonucleotide pair relB2p/relE2tga (right panel) were separated on agarose gels (B). DNAs
from loci relBE2Spn (r) or from yefM-yoeBSpn (y) were isolated from different S. pneumoniae macrolide-resistant strains, as follows: CipR-67 (1); CipR-25
(2); CipR-22 (3); CipR-14 (4); CipR-23 (5); R6wt (C); Mr. Molecular weight standard, Hyper ladder I (BIOLINE).
doi:10.1371/journal.pone.0011289.g004
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the years 1997 to 2002. Spanish and Polish isolates were tested for
presence of the relBE2Spn locus and its flanking regions by
amplification with different oligonucleotides spanning the appropri-
ate regions (Figure 5A).In addition tothose, we checked, through bio-
informatics procedures, the presence of the relBE2Spn operon in
another 31 strains whose sequences are available at the NCBI
Genome Project (http://www.ncbi.nlm.nih.gov/) and at the Sanger
Institute (http://www.sanger.ac.uk/Projects/S_pneumoniae/), thus
making a total of 100 strains analyzed (Table S1). In addition, STs of
sequenced pneumococcal strains for which MLST data was not
available were determined in silico.
The results of the global PCR analyses of the chromosomal
structure of S. pneumoniae around the relBE2Spn locus allowed us to
classify the 100 isolates tested into three categories (Figure 5B and
Table S1): Type I shared the genetic organization found in known
strains (TIGR4, D39, and R6). Type II lacked the open reading
frames (orf) SP1222 and SP1221, which were replaced by an orf
homologous with the cation channel protein family. The genetic
organization of Type III was similar to Type II but, in addition, it
contained a 1200 bp sequence insertion located upstream the
promoter of the relBE2Spn operon. The nucleotide sequence of this
insertion corresponded to the IS1167 transposon sequence, which
includes inverted repeats flanking the transposase [49]. There was
no association of the TAS types with pneumococcal serotypes.
However, a very good concordance was observed in all cases when
more than a single representative of a given ST was analyzed.
Altogether, the latter observation was made for 15 STs that
included 44 isolates. Determination of the nucleotide sequence of
several of the clinical isolates belonging to the three pneumococcal
relBE Types (Table S1) showed no sequence changes in the
antitoxin-encoding relB2Spn gene. However, in the region
encoding the RelE2Spn toxin, several nucleotide changes were
detected. Some of them corresponded to silent mutations (GTC to
GTT at V74; ATC to ATT at I65; GAC to GAT at D39, and
TGA to TAA at the stop codon of the gene). Two other
polymorphisms in which minor amino acid changes occurred were
also found (T34I, and D39G), whereas some strains, like CipR-25
(Figure 5B), exhibited changes in the region spanning the -35 and
-10 region of the relBE2Spn promoter, a region probably involved
in the transcriptional self-regulation of the operon (I. Moreno, C.
Nieto and M. Espinosa, unpublished).
Even though the nucleotide sequence of the relBE2Spn promoter
region in the different types was not essentially modified, synthesis
of the relBE2Spn mRNA (and hence the expression of these two
proteins) could be affected. To detect the relBE2Spn mRNA in
several clinical isolates, primer extension analyses were carried out.
Total RNA was isolated from selected strains belonging to the
three genomic types: i) from Type I, strains R6, and CipR-25, the
latter containing the A/G change at the position -28 in the
relBE2Spn proposed regulatory region; ii) from Type II, strains
CipR-31, CipR-67, and 2115, the latter harbouring also the same
change in the proposed regulatory region, and iii) from Type III,
CipR-51 and CipR-14. In all strains, a primer extension product
was detected (Figure S3) and its size was the same as the one
detected previously for the laboratory R6 strain [33].
Taken together, we can conclude that all strains analyzed
retained the relBE2Spn module, but exhibited three different
genetic arrangements: 21.5%, 61.3% and 17.2% of the analyzed
strains exhibited a genetic organization of the type I, II and III,
respectively; 36% of the sequenced strains bore mutations in the
gene encoding the RelE2Spn toxin. Furthermore, the operon
organization, and thus co-transcription of both genes, was
maintained in all strains tested.
Attenuated toxicity in relE2Spn mutants
As shown above, most of the nucleotide changes identified in the
sequence of the relBE2Spn locus were located within the relE2Spn
gene, two of them being missense mutations that affected the
RelE2Spn toxin: change D39G was found in three strains (Polish
7153, and the NCBI genome project P1031 and JJA), whereas
change T34I was relatively frequent (around 35% of the
sequenced isolates). To verify whether these changes affected the
toxic activity of RelE2Spn, and to elucidate their possible
physiological consequences, we tested toxicity on E. coli cells
based on two criteria previously used for the pneumococcal yefM-
yoeB operon [34]: i) inhibition of cell growth after expression of
either wild type or mutant RelE2Spn, and ii) ability of RelE2Spn to
interact with the cognate RelB2Spn antitoxin in cultures
harbouring uncoupled genes (relB2Spn and relE2Spn) cloned in
two different plasmids under inducible promoters. In the latter
conditions, induction of the antitoxin should neutralize the toxic
effect of RelE2Spn thus permitting bacterial growth. To this end,
DNA fragments containing genes relE2Spn, wt or mutants
harbouring the D39G, T34I, and, as a control, relE2ter (encoding
a truncated and inactive RelE2Spn protein) were cloned into
plasmid pFUS2 [50] under the control of the araBAD promoter
(PBAD), which is inducible by arabinose and repressed by glucose.
The resulting plasmids (Table 1) were termed pE2wt (wt
RelE2Spn), pE71 (D39G RelE2Spn), pE81 (from strain 8651) or
pE600 (from strain k-600), both harbouring the T34I RelE2Spn
mutation and pE2ter (truncated RelE2 protein). In addition, the
relB2Spn wt gene was cloned in plasmid pNM220 [51], which
allows IPTG-inducible expression of the antitoxin from the Plac
promoter; the resulting plasmid was termed pB2wt (Table 1). As
expected, no significant difference in growth rate was observed for
E. coli cells with the control pE2ter upon induction of PBAD.
However, a total growth arrest was observed for E. coli harbouring
the plasmids pE2wt, pE71(D39G), pE81(T34I), or pE600(T34I)
(Figure 6A). Additionally, a severe decrease in the number of
viable cells compared to cultures containing the pE2ter plasmid
was seen (Figure 6B). This reduction in cfu occurred in the
following order: relE2wt (almost four orders of magnitude) .
relE2T34I (nearly two orders) . relE2D39G (twofold). The toxicity
of the RelE2Spn toxin could be counteracted by its cognate
antitoxin, encoded in the pB2wt plasmid. Cells, containing the
different pairs of plasmids were streaked on plates supplemented
with 0.4% arabinose (induction of toxin synthesis) with or without
2 mM IPTG (induction of antitoxin synhtesis). Transformants
containing, in addition to pB2wt, plasmids encoding the toxin
(totally or partially functional) were able to grow only on plates
supplemented with IPTG while control cells harbouring pB2wt
and either pFUS or pE2ter did not show growth differences in the
presence or absence of IPTG (Figure 6C).
Discussion
The human upper respiratory tract is a natural environment for
S. pneumoniae from which these bacteria spread to other body parts
and to new hosts; hence an increase in pneumococcal persistence
during colonization may influence its virulence and epidemicity
[52]. Persistence may be one of the roles performed by the
bacterial TAS by allowing bacteria to survive under nutrient
limited conditions, thereby improving adaptability to selective
pressures and permitting the bacteria to retain their capacity to
colonize humans without reduction in virulence. The pneumo-
coccal relBE2Spn was identified in the chromosome of S. pneumoniae
and shown to be functional, in contrast to the pneumococcal
homologue termed relBE1Spn [16,33]. Cells lacking the relBE2Spn
Pneumococcal Polymorphisms
PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e11289Pneumococcal Polymorphisms
PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e11289operon exhibited the same growth profile and response to sugar
starvation as the wt bacteria did (Figure S1). Differences were
found, however, when cells were subjected to protein synthesis
inhibition either by amino acid starvation or antibiotic treatment.
In the case of the E. coli RelBE, the toxin was activated because of
antitoxin RelB degradation subsequent to inhibition of protein
synthesis [39]. Toxicity of EcoRelE protein is due to cleavage of
translating mRNA at the ribosomal A site [12,53]; other RelE
homologues, including RelE2Spn seem to cleave RNA in a similar
manner, and thus cells exposed to the toxin showed a drastic
growth arrest [16,33]. Similarly, activation of RelE2Spn by SHT
treatment, led to reduction in the number of cfu (Figures 1 and 2),
but this reduction was not due to cell death as detected by the
LIVE/DEAD BacLight bacterial viability method (not shown), but
rather to a slower rate of cell growth. After SHT removal, cells
returned to normal growth, although two major differences were
observed between the wt and the mutant strains (Figures 1 and 2):
i) the wt cells recovered more slowly than the mutants, most likely
because recovery of cell growth of the former required prior
antitoxin synthesis to neutralize the RelE2Spn toxin, and ii) the wt
strain exhibited an exponential growth period after recovery which
was longer than that of the mutant. These results indicated that
the pneumococcal relBE2 system, under amino acid starvation,
could help the bacteria to divert the scarce resources to essential
processes, thus improving its survival potential. Treatment with
Erm (or with Sm) also resulted in a different response in the two
pneumococcal strains used. The wt showed a higher and quicker
reduction in cfu than the mutant (Figures 3B and S2) although, at
0.1 mgm l
21 of Erm, it was not due to diminished cell viability.
However, at 1 mgm l
21 of Erm, a clear loss in viability was
observed for the wt, which was not the case for the mutant
(Figure 3C). The higher sensitivity of the wt strain to a low dosage
of Erm can be explained as the result of RelE2Spn activation
subsequent to protein synthesis inhibition. When higher concen-
trations of the antibiotic were used, cell lysis was observed in the wt
after 180 minutes of treatment and, during the recovery period,
only the mutant cells were able to resume growth but only after
24 hours of Erm removal (not shown).Thus, activation of the
pneumococcal relBE2Spn operon subsequent to antibiotic treat-
ment appeared to induce an extreme interruption of the protein
synthesis, leaving the bacteria unable to recover viability or even
inducing cell death. Then, lack of the relBE2Spn operon in S.
pneumoniae would lead to antibiotic tolerance a role that coincides
with the one proposed for the E. coli mazEF TAS [21].
The pneumococcal relBE2Spn operon is not essential, at least under
the laboratory growth conditions used ([33] and Figure S1), but it
showed a functional conservation in all the strains tested (see below).
This was unlike the two other TAS characterized in S. pneumoniae,
namely pezAT and yoeB-yefMSpn. The former was found to be absent
in several clinical isolates of S. pneumoniae [7], whereas a search for the
presence of yoeB-yefMSpn in 31 pneumococcal strains sequenced
(NCBI project or Sanger institute) showed that more than 40% of
them lacked this TAS (not shown). In E. coli, the homologous relEB
TAS have beenlostin severalstrains [14]. Inaddition, analyses of395
E. coli strains showed decay in the chromosomally-encoded ccdAB
TAS and a molecular evolution analysis of these data suggests that
this TAS does not seem to retain any role in E. coli [54]. A recent
study on comparative metagenomic analyses of plasmid-encoded
functionsinthe human gut microbiomeshowed thattheRelBETAS,
as compared to other TAS, is relatively abundant and retains a broad
phylogenetic distribution in the human gut microbiome, suggesting
that prevalence of RelBE could be related to fitness of the bacterial
host [55]. Our analysis of the relBE2Spn locus showed the existence of
three different genetic organizations, although transcription of the
operon was not affected by these rearrangements (Figure S3). Type II
seems to be most divergent and most prevalent (Table S1). This may
suggest this is an ancestral type. It is easy to imagine how types I and
type III are made by single genetic events from II. Type III looks
homogenous but all the isolates of type III that were sequenced
originated from the same clone so this could have been expected.
In addition to the above arrangements, various isolates showed
several more polymorphisms at the relE2Spn gene, some of them
affecting the amino acid sequence of the protein. Two of them were
found to be relevant, namely changes T34I, and D39G, since toxin
activation in either of the two mutants led to growth arrest, although
theirtoxic effectwaslower than the wt toxin(Figure 6), indicatingthat
these amino acid changes could affect critical residues of the toxin.
We constructed a molecular model of the pneumococcal RelESpn
based on the crystal structures of the RelBE protein complexes of P.
horikoshii (PhRelBE) [10] and the recently published structure of the
RelE protein from Methanococcus jannaschii (MjRelBE) [11]. Amino
acid sequence alignment and the structural model (Figure 7) indicated
that all R residues that were previously related to PhRelE toxicity
(R40, R58, R65, and R85) were conserved in RelE2Spn (R41, R56,
R63, and R83). Curiously, this R-distribution was not fully conserved
inthepneumococcalRelE1Spn(alsopresentintheR6strain;Figure7)
perhaps causing its lack of functionality [33]. In the RelE2Spn
molecular model (Figure 7), residues T34 and D39 (changed in the
RelE2Spn low toxicity mutants to I and G, respectively) appeared to
be located close to the toxicity-related R residues. According to the
structure of toxins Kid and MazF [56–58], we can postulate that: i)
mutation T34I would allow the toxin to retain its RNase activity but
with slight changes in its substrate binding capacity, and ii) D39,
together with E38, are acidic residues that could act in the catalysis of
RNA in the active site of the toxin so that mutation D39G would
reduce the RelE2Spn mRNA cleavage activity, thereby diminishing
RelE2Spn toxicity (Figure 6). The model of RelE2Spn also sheds light
on some possible structural peculiarities of the toxin: unlike its E. coli
and P. horikoshii homologues, RelE2Spn would include in its catalytic
site (besides the conserved R residues), residues H43, Y31 and Y57,
and two acidic residues (E38 and D39) (Figure 7 and Figure S4).
These residues are present in the catalytic site of toxins with
ribosome-independent RNase activity, such as YoeB [6], Kid [57]
and MazF [58]. The presence of these additional residues allow us to
speculate that RelE2Spn could mediate the cleavage of translating
Figure 5. Polymorphisms found at the relBE2Spn locus in clinical isolates of S. pneumoniae. A genetic diagram of the chromosomal region
flanking the relBE2Spn locus in the R6 strain shows that this region includes genes encoding Ldh (lactate dehydrogenase), GyrA (the A subunit of DNA
gyrase), and SP1221 and SP1222 (putative type II restriction endonucleases). These orfs have been detected only in thepneumococcal strains belonging to
Type I, whereas the putative cation channel protein was found in those strains included in both Type II and Type III. Other genes identified in this region
were: relE2 (relBE2Spn locus encoding toxin RelE2), relB2 (relBE2Spn locus encoding antitoxin RelB2), and vicX (encoding VicX protein). The vicx gene
comprises part of the TCS02 operon (vicRKX) essential for pneumococcal viability. In addition, a RUP element has been identified between the ldh and the
sp1221codingregions.RUPelementsareaninsertionsequence(IS)-derivativethatcouldstillbemobile[62].Thecollectionofoligonucleotidesusedarealso
indicated by a number corresponding to the following oligonucleotides: 1,l d h ter,; 2, SP1222; 3,r e l E 2 C; 4,r e l E 2 tga; 5,r e l B 2 C; 6,r e l 2 p 5 9; 7,r e l B 2 p ;8,r e l B 2 N, 9,
relE2N. The genetic organization of the three types of relBE2Spn loci is depicted (A). Illustration of the three types of relBE2Spn locus genetic organization
found out in a collection of S. pneumoniae clinical isolates (B) At the bottom, the region spanning the relBE2Spn promoter [33] is depicted. The location of
the IS1167 transposon and the mutation identified in strain 1531 (CipR-25) are highlighted.
doi:10.1371/journal.pone.0011289.g005
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cleave untranslated mRNA, as shown for EcoliYoeB [6].
Concluding remarks
Our results indicate that the relBE2Spn locus could provide a
mechanism for S. pneumoniae to cope with unfavourable conditions,
allowing the bacteria to efficiently survive and colonize humans.
Further, the results show the importance of TAS as targets for
designing new antimicrobials, which is especially true for bacteria
like S. pneumoniae because of their high recombination rates and,
being naturally competent, horizontal transfer. As a consequence,
the appearance of new polymorphic and antibiotic resistant strains
poses a serious threat for infection management.
Materials and Methods
Bacterial strains, growth conditions and plasmid
constructions
Strains and plasmids used in this study are listed in Table 1. E. coli
cultures were grown in TY medium [59] with selection for ampicillin
resistance (Amp
R,1 5 0 mg.ml
21), or kanamycin resistance (Km
R,
50 mg.ml
21). S. pneumoniae cells were grown in AGCH medium [40]
Figure 6. Functional analysis of RelE2Spn mutants in E. coli. Cell growth arrest subsequent to the expression of the relE2Spn wt gene or the
mutants T34I or D39G E. coli TOP-10 cells harbouring plasmids pE2wt (N), pE71(D39G mutant) (m), pE81(T34I mutant) (¤), pE600 (T34I mutant) (&)o r
pEter as a control (o) were exponentially grown in TY medium containing 0.4% glucose and Km to an OD600 =0.15. Then, cultures received 0.4%
arabinose and growth was measured by determination of the OD600 (A) and by counting the cfu (B), this latter by plating appropriate dilutions on
medium supplemented with 0.4% glucose and Km and incubated overnight at 37uC. All the experiments were performed at least in duplicate. The
effect of the separate and of combined expression of the relE2Spn or relB2Spn in E. coli was also tested on solid medium (C). E. coli TOP-10 cells
harbouring pB2wt and pEter (streak 1), pFSU2 (streak 2), pE2wt (streak 3), pE71 (streak 4); pE81 (streak 5); pE600 (streak 6) were streaked on TY plates
containing Km and Ap, supplemented with 0.4% arabinose and with or without IPTG (2 mM). Arabinose induces the toxin expression, whereas IPTG
(2 mM) promotes the antitoxin overproduction.
doi:10.1371/journal.pone.0011289.g006
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AGCH) medium, with or without selection for resistance to
chloramphenicol (Cm
R,2mg. ml
21). All cultures were grown at
37uC. The agar plates were incubated at 37uC in air. SHT (used at
1.5 mg.ml
21; a compound which specifically blocks charging of
seryl-tRNA, thus inhibiting protein synthesis), Erm (used at 0.1 or
1 mg. ml
21), and Sm (used at 20 mg.ml
21) both of them blocking
bacterial ribosomes, were purchased from Sigma. We used Erm
instead Cm because the mutant strain, R6DrelB2Spn,h a r b o u r sa
chromosomally-integrated copy of the cat gene (Table 1).
Plasmids used in this work were constructed as follows: pE2wt,
pE71, pE81, and pE600: The relE2Spn gene with its own ribosome
binding site was amplified by PCR from chromosomal DNAs of
strains R6 (pE2wt), 7153 (pE71), 8151 (pE81), or K-600 (pE600)
and amplified with primers relE2N (59-CGCG GATCCGATG-
CATGATTTAGGCTTGAAGGATGAATA-39) and relE2tga (59-
CGTGGTACCTCAATAAATATCTCTCCGATGACCAACT-
TC-39). The resulting 290-bp PCR products were digested with
EcoRI and KpnI before ligation into the equivalent sites of pFUS2.
Plasmid pE2ter was randomly isolated during construction of
pE71 and contains a mutation in the relE2sequence changing the
E38 residue for a termination codon, yielding a truncated RelE2
protein. Plasmid pB2wt was constructed by amplification of a
chromosomal DNA fragment encoding gene relB2Spn with its own
ribosome binding site using the primers relB2BamHI (59-
CGGGATCCGTGTTACCATTAAAAAAGGGAGCACA AA-
G-39) and relLCC (59-CGGGGTACCATCGCGAATTC-
TAAAACGTCTTGTT GGAACTAATTTATAC-39). The
resulting 310-bp DNA fragment was digested with BamHI and
EcoRI before ligation into the equivalent sites of pNM220. All
plasmids were rescued by transformation of competent E. coli cells.
Growth and recovery tests in S. pneumoniae cells
Cultures of S. pneumoniae R6 and R6DrelB2Spn were exponen-
tially grown in AGCH complete medium to OD650=0.2 at 37uC.
Then, half of each culture was exposed to the different
experimental conditions: carbon starvation, or addition of SHT
or Erm (or Sm). Growth of treated and untreated cultures was
followed by OD650 and the viability (number of cfu) was measured
by plating serial dilutions of each culture on AGCH plates. After
SHT-, Erm, or Sm-treatment, cultures were washed twice with
pre-warmed AGCH and suspended in the same volume of
complete AGCH drug-free medium. OD650 and viability was then
tested for at least 180 minutes. In the carbon starvation
experiments exponentially growing cultures (to OD650=0.2) were
washed twice in pre-warmed AGCH medium and finally
suspended in the same volume of AGCH medium supplemented
with 0.2% yeast extract and with or without sucrose. Cell growth
and viability were measured as above. All the experiments were
performed at least three times.
Fluorescence microscopy
Cultures of R6 and R6DrelB2Spn were exponentially grown at
OD650 =0.25 in AGCH complete medium at 37uCa n dE r mw a s
added at two concentrations (0.1 mg.ml
21 or 1 mg.ml
21). After
180 min, cells were harvested by centrifugation, washed twice with
Figure 7. Molecular modelling of RelBE2Spn. Structure of RelE from P. hirokoshii (PhRelE) (A) and structural model obtained for the
pneumococcal toxin RelE2Spn (B). Residues important for protein synthesis inhibitory activity of PhRelE are displayed. In the case of RelE2Spn model,
the Arg residues which aligned with those of PhRelE involved in protein synthesis inhibition are shown. Residues changed in the RelE2 pneumococcal
mutants isolated here, T34 and D39, are indicated in red. The sequence alignment of PhRelE, RelE2Spn and RelE1Spn (a pneumococcal non-toxic
homolog) is shown in the bottom of the figure. Residues in the PhRelE, involved in toxin activity are red underlined and the corresponding residues in
RelE1Spn and RelE2Spn are highlighted in the same way. T34 and D39 positions in RelE2Spn are framed in green.
doi:10.1371/journal.pone.0011289.g007
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and stained with the LIVE/DEAD BacLight Bacterial viability kit
(Invitrogen) according to the manufacturer’s instructions. Cells were
visualized using a multidimensional AF6000 LX LEICA microscope
and filter cube L5 for green fluorescence or N5 to detect red
fluorescence.
PCR-based gene detection in S. pneumoniae and MLST
Chromosomal DNAs were extracted using the Bacterial
Genomic DNA Isolation Kit (NORGEN) and chromosomal
DNA (50–100 ng) was added to PCR reactions performed using
Phusion high fidelity DNA polymerase (Finnzymes) and, as
primers, the following oligonucleotides:
yefMN:5 9-CGCGGATCCGCTTGTACAAGTTCCTGACA-
ATTTC-39
yoeBC:5 9-CTGGAATTCCGGTAGAGACTTGAGAAAAA-
GCCTA-39
rel2p59:5 9-CGGAATTCCGATCAGGTTCTTACGCTTG-
GCG-39
relB2p: 59-CAGATAC CGCAACACCATTGACAG-39
relB2N:5 9-TGCTCCCGGGCTATTACATTAAAAGTTTC-
TGAA GCTG-39
relB2C:5 9-CGCGAATTCCTTCCCAAGTAATGGGT TCA-
ACTCC-39
relE2N:5 9-CGCGGATCCGATGCATGATTTAGGCTTGA-
AGGATGAATA-39
relE2tga:5 9-CGTGGTACCTCAATAAATATCTCTCCGAT-
GACCAACTTC-39
SP1222: 59-CCTCACGACTAATCCGTTGCAG-39
ldhter:5 9-GCATCTGCTAA AGAATTACAAGCATCATTG-39
To analyse the IS1167 transposon sequence, a 1750-bp PCR-
DNA fragment including this element was obtained using as
template chromosomal DNA isolated from strain 2167 and, as
primers, relB2p and relB2C. The sequence of this DNA fragment
was determined using primers relB2p, relB2C, and two specific
IS1167 primers: 2167N (59-GTCATAGTAAGGACTAAACATA
TCC-39) and 2167C (59-GAAAAGCGATCAAACAACTCAT-
TAG-39).
MLST based on sequencing of fragments of seven housekeeping
genes, aroE, gdh, gki, recP, spi, xpt and ddl was performed as
described by others [60]. The database http://spneumoniae.mlst.
net/was used to assign allele numbers and STs.
Primer extension analysis
Total RNA was isolated from R6 and from different
pneumococcal isolates with Aurum total RNA minikit (BIO-
RAD). For RNA extraction, 1.5–3 ml of the bacterial cultures in
late exponential phase were centrifuged and the cells were
resuspended in 100 ml of lysis buffer (50 m M Tris-HCl pH 7.6,
1 mM EDTA, 50 mM NaCl, 0.1% sodium deoxycholate). The
cell suspension was incubated 10 min at 30uC and further
preparation was done according to the manufacturer’s instruc-
tions. Primer extension assays were performed as described [61]
using either a radiolabelled relBE2Spn specific primer (relRNA, 59-
GAAACTCCTTCAAACTTAGCC-39) [33] or a malX specific
primer mal1, 59-GTGTAACAGTTCCAAGCACCG-39). The 39-
ends of primers were located 56 nt or 48 nt from the nucleotide A
of the ATG initiation codon of the relB2Spn gene or in the malX
ATG initiation codon, respectively [61].
Model construction
The three-dimensional model of RelE2Spn toxin was constructed
using Geno3D molecular modelling program (pBIL.icp.fr.Geno3D,
http://geno3d-pbil.ibcp.fr) and the 2.3 A ˚ resolution X-ray
crystallographic structure of the P. horikoshii OT3 aRelBE complex
[10] (PDB ID:1wmi), and the 2.1 A ˚ resolution X-ray crystallographic
structure of the M. jannaschiiMjRelBE complex [11], (PDB ID:3BPQ)
as templates. The graphic display was performed with PyMOL
program (DeLano Scientific LLC, http://www.pymol.org).
Web sites
NCBI Genome Project: http://www.ncbi.nlm.nih.gov/
Pneumococcal MLST database: http://spneumoniae.mlst.net/
European Committee on Antimicrobial Susceptibility Testing:
http://www.eucast.org/mic_distributions/
PyMOL: http://www.pymol.org.
Sanger Institute: http://www.sanger.ac.uk/Projects/S_pneumoniae/
Geno 3D: http://geno3d-pbil.ibcp.fr
Supporting Information
Figure S1 Growth profile of S. pneumoniae cells wt and mutant
R6(capital delta)relB2Spn under normal or carbon-starvation
conditions. Pneumococcal strains R6 (triangles) or (capital
delta)relB2Spn (circles) were grown in AGCH complete medium
(A, B). In carbon-starvation conditions (panels C and D), cells
were exponentially grown in AGCH complete medium to an
OD650 =0.2, twice washed, and suspended in the same medium
with (open symbols) or without sucrose (filled symbols). Growth of
the cultures was followed by measurement of OD650 nm (A, C) or
by determination of the number of cfu (B, D).
Found at: doi:10.1371/journal.pone.0011289.s001 (1.35 MB EPS)
Figure S2 Inhibition of protein synthesis mediated by Sm
treatment. S. pneumoniae cells from strains R6 (circles) or
R6(capital delta)relB2Spn (triangles) were grown exponentially
in complete AGCH medium to an OD650 =0.120.14. Then,
Sm (20 (mu)g.ml
21) was added, and incubation was continued
for 180 min more. Growth was followed by measurement of
OD650 nm of the cultures untreated (open symbols) or
treated (closed symbols) with Sm (A). At indicated times
appropriate dilutions of cells were plated and incubated as in
Figure 1 (B).
Found at: doi:10.1371/journal.pone.0011289.s002 (1.11 MB EPS)
Figure S3 Primer extension analysis using total RNA from
different S. pneumoniae clinical isolates. RNA samples from R6 (1)
and the following clinical isolates: CipR25 (2), 2115 (3), CipR67
(4), CipR31 (5); CipR14 (6), and CipR51 (7) were annealed with
[32P]-labelled specific primers mal1 (x; as a control) or with the
relRNA oligonucleotide (r) to detect relBE2Spn mRNA. Ct
Indicates a G+A Maxam and Gilbert sequencing reaction, used
as DNA size marker.
Found at: doi:10.1371/journal.pone.0011289.s003 (0.53 MB EPS)
Figure S4 RelE2Spn three dimensional structural model.
Location of R41, R56, R63, R83, and D39 residues is depicted.
Other residues (Y31 and Y57, H43 and E38) supposedly involved
in the catalytic mechanism are displayed in cyan.
Found at: doi:10.1371/journal.pone.0011289.s004 (1.06 MB EPS)
Table S1
Found at: doi:10.1371/journal.pone.0011289.s005 (0.04 MB
XLS)
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